COBO MARC enters BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. with 5.43K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/30/2026ACC: 0001193125-26-197373
Officer· Principal Accounting Officer
Since Apr 2026
5.43K
Baseline shares
100% direct
5.43K
Direct ownership
1 position
154.22K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned5.43K
Total
5.43K direct5.43K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.43K | Direct |
| Total | 5.43K | 5.43K direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
129.09K
Shares owned
N/A
Exercise price
9.59
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
25.13K
Shares owned
N/A
Exercise price
10.19
Expiration
—
Exercise window
—
Total
Underlying
154.22K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 9.59 | — | — | 129.09K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 10.19 | — | — | 25.13K | N/A |
| Total | 154.22K | 0.00 | ||||